ENMD Financial Facts
Research and development: 1.01MNet loss per share (basic and diluted): -0.03
See Full Income Statement
Accrued liabilities: 161.98K
Total assets: 24.76M
See Full Balance Sheet
EntreMed Inc. (ENMD) Earnings
|
Expand Research on ENMD
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +1.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/15/14 | Q114 | -$0.05 | -$0.05 | $0.00 | N/A | N/A | N/A | Details | |||
3/21/14 | Q413 | -$0.05 | N/A | N/A | N/A | $669.3K | N/A | Details | |||
11/14/13 | Q313 | -$0.05 | -$0.05 | $0.00 | N/A | N/A | N/A | Details | |||
8/14/13 | Q213 | -$0.07 | N/A | N/A | N/A | N/A | N/A | Details | |||
5/15/13 | Q113 | -$0.05 | N/A | N/A | N/A | N/A | N/A | Details | |||
3/21/13 | Q412 | -$0.02 | N/A | N/A | $669.31K | $1.93M | N/A | Details | |||
11/14/12 | Q312 | -$0.05 | N/A | N/A | N/A | N/A | N/A | Details | |||
8/14/12 | Q212 | -$0.56 | N/A | N/A | N/A | N/A | N/A | Details |